​Palmitoylethanolamide Infection – Influenza and Common Cold

Palmitolyethanolamide (PEA) Shown To Be Effective In Reducing Influenza & Common Cold

 

It is not well known that over the past 25 years, PEA (Palmitoylethanolamide) has been tested as a therapy for both influenza and the common cold.  In fact, as early as 1939, food supplements (dried egg yolks fed to poor children in New York which containing high PEA) reduced rheumatic fever and streptococcal infections.  

This progressed over several decades leading to research in 1974 (Masek et al) that showed a 52% reduction in influenza in a trial with 1344 subjects.  People taking the palmitoylethanolamide had fewer episodes of fever, sore throat and headache than the placebo groups.  The number of sickness days was reduced in the PEA group.

To confirm these results – it was decided to test it on the military.

Soldiers that housed together were selected, and over 2 years from 1973 to 1975, new trials were conducted. 

The group taking the supplement had approximately one third the infection rate of the placebo group.

What else don’t you know about supplements?

Read more about palmitoylethanolamide at:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771453/